The metabolism of doxycycline can be decreased when combined with loratadine.


The metabolism of clotrimazole can be decreased when combined with loratadine.


The metabolism of VERAPAMIL can be decreased when combined with EXEMESTANE.


The metabolism of fluvastatin can be decreased when combined with antipyrine.


The metabolism of Ziprasidone can be decreased when combined with mebendazole.


The metabolism of leflunomide can be decreased when combined with antipyrine.


The metabolism of nefazodone can be decreased when combined with Vitamin D3.


The metabolism of diltiazem can be decreased when combined with Lumefantrine.


The metabolism of fluconazole can be decreased when combined with doxazosin.


The metabolism of CAPECITABINE can be decreased when combined with IDARUBICIN.


The metabolism of nefazodone can be decreased when combined with tamoxifen.


The metabolism of sertraline can be decreased when combined with IDARUBICIN.


The metabolism of Voriconazole can be decreased when combined with clindamycin.


The metabolism of clotrimazole can be decreased when combined with loperamide.


The metabolism of Isavuconazonium can be decreased when combined with ambroxol.


The metabolism of Dronedarone can be decreased when combined with tretinoin.


The metabolism of ritonavir can be decreased when combined with nicotine.


The metabolism of haloperidol can be decreased when combined with nicotine.


The metabolism of Esomeprazole can be decreased when combined with thioridazine.


The metabolism of fluvoxamine can be decreased when combined with Regorafenib.


The metabolism of omeprazole can be decreased when combined with methadone.


The metabolism of Mirabegron can be decreased when combined with promethazine.


The metabolism of paroxetine can be decreased when combined with Cevimeline.


The metabolism of Posaconazole can be decreased when combined with chlordiazepoxide.


The metabolism of Olaparib can be decreased when combined with chlordiazepoxide.


The metabolism of RUCAPARIB can be decreased when combined with clofazimine.


The metabolism of nefazodone can be decreased when combined with nitrendipine.


The metabolism of Zucapsaicin can be decreased when combined with tamoxifen.


The metabolism of Cobicistat can be decreased when combined with SERATRODAST.


The metabolism of Quinine can be decreased when combined with mycophenolate mofetil.


The metabolism of fluoxetine can be decreased when combined with LISURIDE.


The metabolism of duloxetine can be decreased when combined with LISURIDE.


The metabolism of Cinacalcet can be decreased when combined with cephalexin.


The metabolism of Atazanavir can be decreased when combined with nisoldipine.


The metabolism of sulfadiazine can be decreased when combined with dextromethorphan.


The metabolism of fluvoxamine can be decreased when combined with epoprostenol.


The metabolism of valsartan can be decreased when combined with epoprostenol.


The metabolism of sildenafil can be decreased when combined with rabeprazole.


The metabolism of terbinafine can be decreased when combined with Quinine.


The metabolism of sildenafil can be decreased when combined with Levocetirizine.


The metabolism of Atomoxetine can be decreased when combined with epinastine.


The metabolism of cocaine can be decreased when combined with Ethylmorphine.


The metabolism of indinavir can be decreased when combined with doxazosin.


The metabolism of tranylcypromine can be decreased when combined with progesterone.


The metabolism of nelfinavir can be decreased when combined with doxazosin.


The metabolism of clemastine can be decreased when combined with epinastine.


The metabolism of Alogliptin can be decreased when combined with diltiazem.


The metabolism of terbinafine can be decreased when combined with METHAMPHETAMINE.


The metabolism of PRIMAQUINE can be decreased when combined with atenolol.


The metabolism of efavirenz can be decreased when combined with Enasidenib.


The metabolism of nicardipine can be decreased when combined with Enasidenib.


The metabolism of Dronedarone can be decreased when combined with hydromorphone.


The metabolism of itraconazole can be decreased when combined with promazine.


The metabolism of Tenofovir disoproxil can be decreased when combined with bupropion.


The metabolism of Darunavir can be decreased when combined with Asenapine.


The metabolism of Escitalopram can be decreased when combined with methadone.


The metabolism of ticlopidine can be decreased when combined with VERAPAMIL.


The metabolism of Telithromycin can be decreased when combined with nicardipine.


The metabolism of Idelalisib can be decreased when combined with galanthamine.


The metabolism of amiodarone can be decreased when combined with APRINDINE.


The metabolism of felodipine can be decreased when combined with PARAMETHADIONE.


The metabolism of nicardipine can be decreased when combined with Remoxipride.


The metabolism of Vitamin D3 can be decreased when combined with trimipramine.


The metabolism of cocaine can be decreased when combined with domperidone.


The metabolism of Voriconazole can be decreased when combined with mefloquine.


The metabolism of Delavirdine can be decreased when combined with nitrazepam.


The metabolism of quinidine can be decreased when combined with domperidone.


The metabolism of tranylcypromine can be decreased when combined with haloperidol.


The metabolism of chloramphenicol can be decreased when combined with clarithromycin.


The metabolism of nicardipine can be decreased when combined with loratadine.


The metabolism of Telaprevir can be decreased when combined with Grazoprevir.


The metabolism of diltiazem can be decreased when combined with buspirone.


The metabolism of VERAPAMIL can be decreased when combined with Pipotiazine.


The metabolism of Rolapitant can be decreased when combined with nifedipine.


The metabolism of amiodarone can be decreased when combined with Ambrisentan.


The metabolism of ritonavir can be decreased when combined with amsacrine.


The metabolism of isoniazid can be decreased when combined with chlorpheniramine.


The metabolism of cimetidine can be decreased when combined with amsacrine.


The metabolism of RUCAPARIB can be decreased when combined with carisoprodol.


The metabolism of Zucapsaicin can be decreased when combined with Prostaglandin E2.


The metabolism of Lumefantrine can be decreased when combined with Enasidenib.


The metabolism of amiodarone can be decreased when combined with theophylline.


The metabolism of cyclosporin A can be decreased when combined with Brivaracetam.


The metabolism of Atomoxetine can be decreased when combined with losartan.


The metabolism of sulfisoxazole can be decreased when combined with suprofen.


The metabolism of Ziprasidone can be decreased when combined with theophylline.


The metabolism of Midostaurin can be decreased when combined with promazine.


The metabolism of clemastine can be decreased when combined with losartan.


The metabolism of venlafaxine can be decreased when combined with losartan.


The metabolism of clotrimazole can be decreased when combined with Frovatriptan.


The metabolism of dihydroergotamine can be decreased when combined with aminophylline.


The metabolism of Eslicarbazepine acetate can be decreased when combined with cyclophosphamide.


The metabolism of clomipramine can be decreased when combined with flunarizine.


The metabolism of gemfibrozil can be decreased when combined with flunarizine.


The metabolism of fluvoxamine can be decreased when combined with Pimecrolimus.


The metabolism of Quinine can be decreased when combined with aspirin.


The metabolism of Dothiepin can be decreased when combined with Pazopanib.


The metabolism of Telithromycin can be decreased when combined with pilocarpine.


The metabolism of Idelalisib can be decreased when combined with Perospirone.


The metabolism of caffeine can be decreased when combined with Melatonin.


The metabolism of Cobicistat can be decreased when combined with Cinacalcet.


The metabolism of sildenafil can be decreased when combined with Melatonin.


The metabolism of RUCAPARIB can be decreased when combined with lomefloxacin.


The metabolism of azithromycin can be decreased when combined with Melatonin.


The metabolism of Mexiletine can be decreased when combined with Etoricoxib.


The metabolism of diltiazem can be decreased when combined with promazine.


The metabolism of RANOLAZINE can be decreased when combined with APRINDINE.


The metabolism of Ziprasidone can be decreased when combined with APRINDINE.


The metabolism of Darunavir can be decreased when combined with praziquantel.


The metabolism of SAQUINAVIR can be decreased when combined with gemfibrozil.


The metabolism of Posaconazole can be decreased when combined with praziquantel.


The metabolism of duloxetine can be decreased when combined with Gefitinib.


The metabolism of fluoxetine can be decreased when combined with Gefitinib.


The metabolism of Voriconazole can be decreased when combined with Cinacalcet.


The metabolism of Lobeglitazone can be decreased when combined with domperidone.


The metabolism of diltiazem can be decreased when combined with bromocriptine.


The metabolism of Lumefantrine can be decreased when combined with METHAMPHETAMINE.


The metabolism of Zucapsaicin can be decreased when combined with Esomeprazole.


The metabolism of Atazanavir can be decreased when combined with doxorubicin.


The metabolism of diphenhydramine can be decreased when combined with doxorubicin.


The metabolism of Esomeprazole can be decreased when combined with cyclophosphamide.


The metabolism of citalopram can be decreased when combined with tolperisone.


The metabolism of clemastine can be decreased when combined with haloperidol.


The metabolism of lidocaine can be decreased when combined with haloperidol.


The metabolism of Lopinavir can be decreased when combined with ajmaline.


The metabolism of leflunomide can be decreased when combined with quinidine.


The metabolism of Lapatinib can be decreased when combined with Apixaban.


The metabolism of bupropion can be decreased when combined with haloperidol.


The metabolism of cocaine can be decreased when combined with citalopram.


The metabolism of Posaconazole can be decreased when combined with albendazole.


The metabolism of Crisaborole can be decreased when combined with hydromorphone.


The metabolism of Darunavir can be decreased when combined with albendazole.


The metabolism of VERAPAMIL can be decreased when combined with methylprednisolone.


The metabolism of rabeprazole can be decreased when combined with lidocaine.


The metabolism of desipramine can be decreased when combined with Dapagliflozin.


The metabolism of chloramphenicol can be decreased when combined with Escitalopram.


The metabolism of tolbutamide can be decreased when combined with lidocaine.


The metabolism of felodipine can be decreased when combined with testosterone.


The metabolism of fluvoxamine can be decreased when combined with Dasabuvir.


The metabolism of Dothiepin can be decreased when combined with nicardipine.


The metabolism of Fosamprenavir can be decreased when combined with nicardipine.


The metabolism of Isavuconazonium can be decreased when combined with cisapride.


The metabolism of irbesartan can be decreased when combined with testosterone.


The metabolism of dihydroergotamine can be decreased when combined with Brivaracetam.


The metabolism of floxuridine can be decreased when combined with Brivaracetam.


The metabolism of sildenafil can be decreased when combined with Lumiracoxib.


The metabolism of Dothiepin can be decreased when combined with methoxyflurane.


The metabolism of caffeine can be decreased when combined with Lumiracoxib.


The metabolism of azithromycin can be decreased when combined with Lumiracoxib.


The metabolism of pyrimethamine can be decreased when combined with Lumiracoxib.


The metabolism of terbinafine can be decreased when combined with sertraline.


The metabolism of ticlopidine can be decreased when combined with Lumiracoxib.


The metabolism of Dothiepin can be decreased when combined with Bortezomib.


The metabolism of Levomepromazine can be decreased when combined with BISOPROLOL.


The metabolism of tranylcypromine can be decreased when combined with chloramphenicol.


The metabolism of chloramphenicol can be decreased when combined with cyclophosphamide.


The metabolism of chloramphenicol can be decreased when combined with benztropine.


The metabolism of Mexiletine can be decreased when combined with Almotriptan.


The metabolism of Boceprevir can be decreased when combined with phenoxybenzamine.


The metabolism of Fosamprenavir can be decreased when combined with dapsone.


The metabolism of 5-Fluorouracil can be decreased when combined with nevirapine.


The metabolism of Lopinavir can be decreased when combined with dextromethorphan.


The metabolism of Fosamprenavir can be decreased when combined with citalopram.


The metabolism of doxycycline can be decreased when combined with alclometasone.


The metabolism of Quinine can be decreased when combined with METHAMPHETAMINE.


The metabolism of Armodafinil can be decreased when combined with Pipotiazine.


The metabolism of Posaconazole can be decreased when combined with Deutetrabenazine.


The metabolism of Voriconazole can be decreased when combined with sertraline.


The metabolism of erythromycin can be decreased when combined with nicardipine.


The metabolism of Pioglitazone can be decreased when combined with acetaminophen.


The metabolism of Ziprasidone can be decreased when combined with flunisolide.


The metabolism of promazine can be decreased when combined with piperazine.


The metabolism of Isavuconazonium can be decreased when combined with teniposide.


The metabolism of Topiroxostat can be decreased when combined with testosterone.


The metabolism of sildenafil can be decreased when combined with triazolam.


The metabolism of Lobeglitazone can be decreased when combined with Erlotinib.


The metabolism of ticlopidine can be decreased when combined with triazolam.


The metabolism of Telithromycin can be decreased when combined with Dapagliflozin.


The metabolism of nelfinavir can be decreased when combined with bicalutamide.


The metabolism of lovastatin can be decreased when combined with bicalutamide.


The metabolism of indinavir can be decreased when combined with bicalutamide.


The metabolism of Lumefantrine can be decreased when combined with Nitrofural.


The metabolism of fluvoxamine can be decreased when combined with chlorpheniramine.


The metabolism of Dronedarone can be decreased when combined with promazine.


The metabolism of nefazodone can be decreased when combined with Neratinib.


The metabolism of Ticagrelor can be decreased when combined with valsartan.


The metabolism of ticlopidine can be decreased when combined with Rupatadine.


The metabolism of fluoxetine can be decreased when combined with dopamine.


The metabolism of Lopinavir can be decreased when combined with carvedilol.


The metabolism of SAQUINAVIR can be decreased when combined with PERHEXILINE.


The metabolism of duloxetine can be decreased when combined with dopamine.


The metabolism of sulfadiazine can be decreased when combined with Trabectedin.


The metabolism of Isavuconazonium can be decreased when combined with spiramycin.


The metabolism of VERAPAMIL can be decreased when combined with aminophylline.


The metabolism of ketoconazole can be decreased when combined with KETAZOLAM.


The metabolism of Telaprevir can be decreased when combined with tetracycline.


The metabolism of Imatinib can be decreased when combined with norethindrone.


The metabolism of cyclosporin A can be decreased when combined with Macitentan.


The metabolism of Telaprevir can be decreased when combined with aminophylline.


The metabolism of clemastine can be decreased when combined with Nilotinib.


The metabolism of cimetidine can be decreased when combined with quetiapine.


The metabolism of haloperidol can be decreased when combined with quetiapine.


The metabolism of Rolapitant can be decreased when combined with astemizole.


The metabolism of Topiroxostat can be decreased when combined with ZILEUTON.


The metabolism of bupropion can be decreased when combined with Pazopanib.


The metabolism of sulfadiazine can be decreased when combined with Dapagliflozin.


The metabolism of leflunomide can be decreased when combined with VORTIOXETINE.


The metabolism of ticlopidine can be decreased when combined with propofol.


The metabolism of fluvastatin can be decreased when combined with VORTIOXETINE.


The metabolism of fluconazole can be decreased when combined with letrozole.


The metabolism of Dothiepin can be decreased when combined with ondansetron.


The metabolism of cyclosporin A can be decreased when combined with Lapatinib.


The metabolism of pyrimethamine can be decreased when combined with propofol.


The metabolism of sildenafil can be decreased when combined with propofol.


The metabolism of caffeine can be decreased when combined with propofol.


The metabolism of sulfisoxazole can be decreased when combined with sibutramine.


The metabolism of fluvoxamine can be decreased when combined with sulfinpyrazone.


The metabolism of valsartan can be decreased when combined with sulfinpyrazone.


The metabolism of fluconazole can be decreased when combined with sevoflurane.


The metabolism of Rolapitant can be decreased when combined with carvedilol.


The metabolism of Rolapitant can be decreased when combined with acetylcholine.


The metabolism of Rolapitant can be decreased when combined with ondansetron.


The metabolism of Imatinib can be decreased when combined with benzphetamine.


The metabolism of diltiazem can be decreased when combined with oxybutynin.


The metabolism of trimethoprim can be decreased when combined with donepezil.


The metabolism of diltiazem can be decreased when combined with warfarin.


The metabolism of indinavir can be decreased when combined with sevoflurane.


The metabolism of lovastatin can be decreased when combined with sevoflurane.


The metabolism of imipramine can be decreased when combined with Debrisoquine.


The metabolism of nelfinavir can be decreased when combined with sevoflurane.


The metabolism of Mexiletine can be decreased when combined with trifluoperazine.


The metabolism of nicardipine can be decreased when combined with zaltoprofen.


The metabolism of efavirenz can be decreased when combined with zaltoprofen.


The metabolism of chloramphenicol can be decreased when combined with Gliquidone.


The metabolism of Vitamin D3 can be decreased when combined with Vismodegib.


The metabolism of clotrimazole can be decreased when combined with ipratropium.


The metabolism of doxycycline can be decreased when combined with ipratropium.


The metabolism of valsartan can be decreased when combined with halothane.


The metabolism of fluvoxamine can be decreased when combined with halothane.


The metabolism of AMPHETAMINE can be decreased when combined with apomorphine.


The metabolism of clotrimazole can be decreased when combined with etodolac.


The metabolism of Darunavir can be decreased when combined with clonazepam.


The metabolism of Posaconazole can be decreased when combined with clonazepam.


The metabolism of Quinine can be decreased when combined with oxymorphone.


The metabolism of Lobeglitazone can be decreased when combined with oxaprozin.


The metabolism of RUCAPARIB can be decreased when combined with hydrocortisone.


The metabolism of Voriconazole can be decreased when combined with norethindrone.


The metabolism of moclobemide can be decreased when combined with diltiazem.


The metabolism of floxuridine can be decreased when combined with Torasemide.


The metabolism of Quinine can be decreased when combined with Zuclopenthixol.


The metabolism of thioridazine can be decreased when combined with benzyl alcohol.


The metabolism of VALPROIC ACID can be decreased when combined with Lornoxicam.


The metabolism of Boceprevir can be decreased when combined with dolasetron.


The metabolism of nefazodone can be decreased when combined with pentamidine.


The metabolism of erythromycin can be decreased when combined with ethinyl estradiol.


The metabolism of fluvoxamine can be decreased when combined with vinorelbine.


The metabolism of terbinafine can be decreased when combined with UMECLIDINIUM.


The metabolism of fluconazole can be decreased when combined with ethinyl estradiol.


The metabolism of chloramphenicol can be decreased when combined with diphenhydramine.


The metabolism of trimethoprim can be decreased when combined with diphenhydramine.


The metabolism of floxuridine can be decreased when combined with Prasugrel.


The metabolism of dihydroergotamine can be decreased when combined with Prasugrel.


The metabolism of terbinafine can be decreased when combined with cinnarizine.


The metabolism of Dronedarone can be decreased when combined with ethinyl estradiol.


The metabolism of trimethoprim can be decreased when combined with estradiol.


The metabolism of chloramphenicol can be decreased when combined with estradiol.


The metabolism of SAQUINAVIR can be decreased when combined with temazepam.


The metabolism of leflunomide can be decreased when combined with LESINURAD.


The metabolism of fluvastatin can be decreased when combined with LESINURAD.


The metabolism of 5-Fluorouracil can be decreased when combined with temazepam.


The metabolism of venlafaxine can be decreased when combined with triamcinolone.


The metabolism of Delavirdine can be decreased when combined with Letermovir.


The metabolism of indinavir can be decreased when combined with valsartan.


The metabolism of lovastatin can be decreased when combined with valsartan.


The metabolism of zafirlukast can be decreased when combined with temazepam.


The metabolism of tolbutamide can be decreased when combined with nicotine.


The metabolism of Mexiletine can be decreased when combined with clenbuterol.


The metabolism of Delavirdine can be decreased when combined with fenofibrate.


The metabolism of amiodarone can be decreased when combined with doxepin.


The metabolism of 5-Fluorouracil can be decreased when combined with tenoxicam.


The metabolism of citalopram can be decreased when combined with Vernakalant.


The metabolism of nevirapine can be decreased when combined with Pimecrolimus.


The metabolism of diltiazem can be decreased when combined with nicotine.


The metabolism of cyclosporin A can be decreased when combined with flutamide.


The metabolism of amiodarone can be decreased when combined with TASOSARTAN.


The metabolism of cimetidine can be decreased when combined with ritonavir.


The metabolism of isoniazid can be decreased when combined with methyprylon.


The metabolism of VERAPAMIL can be decreased when combined with Retapamulin.


The metabolism of caffeine can be decreased when combined with daunorubicin.


The metabolism of zafirlukast can be decreased when combined with selegiline.


The metabolism of sildenafil can be decreased when combined with daunorubicin.


The metabolism of thioridazine can be decreased when combined with Deutetrabenazine.


The metabolism of azithromycin can be decreased when combined with daunorubicin.


The metabolism of ticlopidine can be decreased when combined with daunorubicin.


The metabolism of nicardipine can be decreased when combined with glipizide.


The metabolism of efavirenz can be decreased when combined with glipizide.


The metabolism of Dronedarone can be decreased when combined with Bexarotene.


The metabolism of 5-Fluorouracil can be decreased when combined with selegiline.


The metabolism of clemastine can be decreased when combined with Dutasteride.


The metabolism of isradipine can be decreased when combined with EXEMESTANE.


The metabolism of Zucapsaicin can be decreased when combined with maprotiline.


The metabolism of Bortezomib can be decreased when combined with Hexobarbital.


The metabolism of terbinafine can be decreased when combined with Perospirone.


The metabolism of Eslicarbazepine acetate can be decreased when combined with Levomilnacipran.


The metabolism of Atomoxetine can be decreased when combined with Dutasteride.


The metabolism of clotrimazole can be decreased when combined with rizatriptan.


The metabolism of Ticagrelor can be decreased when combined with PHENPROCOUMON.


The metabolism of dihydroergotamine can be decreased when combined with L-thyroxine.


The metabolism of quinidine can be decreased when combined with citalopram.


The metabolism of itraconazole can be decreased when combined with Lorcaserin.


The metabolism of Cinacalcet can be decreased when combined with dolasetron.


The metabolism of diphenhydramine can be decreased when combined with prochlorperazine.


The metabolism of Atazanavir can be decreased when combined with prochlorperazine.


The metabolism of Dronedarone can be decreased when combined with nifedipine.


The metabolism of Midostaurin can be decreased when combined with Dexmethylphenidate.


The metabolism of promazine can be decreased when combined with doxazosin.


The metabolism of sulfamethoxazole can be decreased when combined with Ximelagatran.


The metabolism of SIMEPREVIR can be decreased when combined with Dexfenfluramine.


The metabolism of pantoprazole can be decreased when combined with zidovudine.


The metabolism of citalopram can be decreased when combined with zidovudine.


The metabolism of Cinacalcet can be decreased when combined with Dexfenfluramine.


The metabolism of RUCAPARIB can be decreased when combined with paramethasone.


The metabolism of Atomoxetine can be decreased when combined with Dexmethylphenidate.


The metabolism of clemastine can be decreased when combined with Dexmethylphenidate.


The metabolism of venlafaxine can be decreased when combined with Dexmethylphenidate.


The metabolism of Dothiepin can be decreased when combined with toremifene.


The metabolism of Levomepromazine can be decreased when combined with nicergoline.


The metabolism of citalopram can be decreased when combined with carvedilol.


The metabolism of PRIMAQUINE can be decreased when combined with betaxolol.


The metabolism of Lobeglitazone can be decreased when combined with pyrazinamide.


The metabolism of isoniazid can be decreased when combined with Mirabegron.


The metabolism of rabeprazole can be decreased when combined with nicotine.


The metabolism of Dronedarone can be decreased when combined with PRIMAQUINE.


The metabolism of Darunavir can be decreased when combined with Reboxetine.


The metabolism of Posaconazole can be decreased when combined with Reboxetine.


The metabolism of Imatinib can be decreased when combined with Ramelteon.


The metabolism of Ziprasidone can be decreased when combined with Venetoclax.


The metabolism of sertraline can be decreased when combined with Deutetrabenazine.


The metabolism of zafirlukast can be decreased when combined with tenoxicam.


The metabolism of nefazodone can be decreased when combined with Palonosetron.


The metabolism of Delavirdine can be decreased when combined with desipramine.


The metabolism of Topiroxostat can be decreased when combined with Arformoterol.


The metabolism of promazine can be decreased when combined with Remoxipride.


The metabolism of RANOLAZINE can be decreased when combined with cyclobenzaprine.


The metabolism of Ziprasidone can be decreased when combined with cyclobenzaprine.


The metabolism of Darunavir can be decreased when combined with Salmeterol.


The metabolism of Posaconazole can be decreased when combined with Salmeterol.


atorvastatin may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


colchicine may increase the myopathic rhabdomyolysis activities of fenofibrate.


Coenzyme Q10 may increase the myopathic rhabdomyolysis activities of bezafibrate.


Coenzyme Q10 may increase the myopathic rhabdomyolysis activities of colchicine.


pravastatin may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


Trabectedin may increase the myopathic rhabdomyolysis activities of Rosuvastatin.


pravastatin may increase the myopathic rhabdomyolysis activities of colchicine.


colchicine may increase the myopathic rhabdomyolysis activities of clofibrate.


pravastatin may increase the myopathic rhabdomyolysis activities of bezafibrate.


Trabectedin may increase the myopathic rhabdomyolysis activities of fluvastatin.


gemfibrozil may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


Etofibrate may increase the myopathic rhabdomyolysis activities of Raltegravir.


fluvastatin may increase the myopathic rhabdomyolysis activities of gemfibrozil.


fluvastatin may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


Fenofibric acid may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


atorvastatin may increase the myopathic rhabdomyolysis activities of Raltegravir.


atorvastatin may increase the myopathic rhabdomyolysis activities of gemfibrozil.


colchicine may increase the myopathic rhabdomyolysis activities of Etofibrate.


Trabectedin may increase the myopathic rhabdomyolysis activities of pravastatin.


Trabectedin may increase the myopathic rhabdomyolysis activities of atorvastatin.


Pitavastatin may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


simvastatin may increase the myopathic rhabdomyolysis activities of azithromycin.


simvastatin may increase the myopathic rhabdomyolysis activities of Raltegravir.


Trabectedin may increase the myopathic rhabdomyolysis activities of lovastatin.


clofibrate may increase the myopathic rhabdomyolysis activities of Raltegravir.


colchicine may increase the myopathic rhabdomyolysis activities of Fenofibric acid.


simvastatin may increase the myopathic rhabdomyolysis activities of gemfibrozil.


lovastatin may increase the myopathic rhabdomyolysis activities of Raltegravir.


bezafibrate may increase the myopathic rhabdomyolysis activities of Raltegravir.


Rosuvastatin may increase the myopathic rhabdomyolysis activities of colchicine.


lovastatin may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


clofibrate may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


colchicine may increase the myopathic rhabdomyolysis activities of bezafibrate.


Rosuvastatin may increase the myopathic rhabdomyolysis activities of bezafibrate.


Coenzyme Q10 may increase the myopathic rhabdomyolysis activities of Raltegravir.


pravastatin may increase the myopathic rhabdomyolysis activities of Raltegravir.


lovastatin may increase the myopathic rhabdomyolysis activities of azithromycin.


bezafibrate may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


gemfibrozil may increase the myopathic rhabdomyolysis activities of Raltegravir.


colchicine may increase the myopathic rhabdomyolysis activities of gemfibrozil.


fenofibrate may increase the myopathic rhabdomyolysis activities of Raltegravir.


Etofibrate may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


Pitavastatin may increase the myopathic rhabdomyolysis activities of Raltegravir.


Rosuvastatin may increase the myopathic rhabdomyolysis activities of gemfibrozil.


lovastatin may increase the myopathic rhabdomyolysis activities of RANOLAZINE.


simvastatin may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


Coenzyme Q10 may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


Pitavastatin may increase the myopathic rhabdomyolysis activities of gemfibrozil.


fenofibrate may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


Trabectedin may increase the myopathic rhabdomyolysis activities of Coenzyme Q10.


lovastatin may increase the myopathic rhabdomyolysis activities of bezafibrate.


Trabectedin may increase the myopathic rhabdomyolysis activities of simvastatin.


fluvastatin may increase the myopathic rhabdomyolysis activities of Raltegravir.


Rosuvastatin may increase the myopathic rhabdomyolysis activities of ACIPIMOX.


Rosuvastatin may increase the myopathic rhabdomyolysis activities of Raltegravir.


fluvastatin may increase the myopathic rhabdomyolysis activities of colchicine.


atorvastatin may increase the myopathic rhabdomyolysis activities of bezafibrate.


atorvastatin may increase the myopathic rhabdomyolysis activities of colchicine.


fluvastatin may increase the myopathic rhabdomyolysis activities of bezafibrate.


simvastatin may increase the myopathic rhabdomyolysis activities of colchicine.


simvastatin may increase the myopathic rhabdomyolysis activities of bezafibrate.


lovastatin may increase the myopathic rhabdomyolysis activities of gemfibrozil.


Trabectedin may increase the myopathic rhabdomyolysis activities of Pitavastatin.


atorvastatin may increase the myopathic rhabdomyolysis activities of azithromycin.


zidovudine may increase the myopathic rhabdomyolysis activities of Raltegravir.


Pitavastatin may increase the myopathic rhabdomyolysis activities of colchicine.


Pitavastatin may increase the myopathic rhabdomyolysis activities of bezafibrate.


pravastatin may increase the myopathic rhabdomyolysis activities of gemfibrozil.


Fenofibric acid may increase the myopathic rhabdomyolysis activities of Raltegravir.


The risk or severity of adverse effects can be increased when nalbuphine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with dobutamine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with procaine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when nalbuphine is combined with gabapentin.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with brotizolam.


The risk or severity of adverse effects can be increased when vindesine is combined with clozapine.


The risk or severity of adverse effects can be increased when ibudilast is combined with salicylic acid.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with potassium ion.


The risk or severity of adverse effects can be increased when nefazodone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Etomidate.


The risk or severity of adverse effects can be increased when alprazolam is combined with glutethimide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with sulpiride.


The risk or severity of adverse effects can be increased when Tramadol is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Tramadol is combined with morphine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with nimesulide.


The risk or severity of adverse effects can be increased when cerulenin is combined with diltiazem.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with isradipine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with clomipramine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when quazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with budesonide.


The risk or severity of adverse effects can be increased when efavirenz is combined with Retigabine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when reserpine is combined with carbamazepine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when atenolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when floxuridine is combined with clozapine.


The risk or severity of adverse effects can be increased when dibucaine is combined with desipramine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Trospium is combined with nalbuphine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with lomustine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Asenapine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with epirizole.


The risk or severity of adverse effects can be increased when LISURIDE is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when methimazole is combined with clozapine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when buspirone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when diltiazem is combined with Eprosartan.


The risk or severity of adverse effects can be increased when nabumetone is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when clemastine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when nabumetone is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when nabumetone is combined with etodolac.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Halazepam.


The risk or severity of adverse effects can be increased when desoximetasone is combined with physostigmine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with proparacaine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Iloperidone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with metolazone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with promethazine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when methadone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when methadone is combined with zaleplon.


The risk or severity of adverse effects can be increased when selegiline is combined with clenbuterol.


The risk or severity of adverse effects can be increased when methadone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with quinapril.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when terbutaline is combined with clenbuterol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with bumetanide.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when alprazolam is combined with scopolamine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with furosemide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with tizanidine.


The risk or severity of adverse effects can be increased when minoxidil is combined with nadolol.


The risk or severity of adverse effects can be increased when fosinopril is combined with propranolol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when meperidine is combined with Drospirenone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with triprolidine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with desipramine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with terazosin.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with methylphenidate.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when diazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Propacetamol.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with galanthamine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with midodrine.


The risk or severity of adverse effects can be increased when pancuronium is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when thiopental is combined with ethotoin.


The risk or severity of adverse effects can be increased when thalidomide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when diazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when brotizolam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with dibucaine.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Pizotifen.


The risk or severity of adverse effects can be increased when thiopental is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with diltiazem.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Tolcapone is combined with protriptyline.


The risk or severity of adverse effects can be increased when olanzapine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with procarbazine.


The risk or severity of adverse effects can be increased when atenolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when lisinopril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Melatonin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with betamethasone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with thioridazine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Efonidipine is combined with propofol.


The risk or severity of adverse effects can be increased when clorazepate is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Escitalopram.


The risk or severity of adverse effects can be increased when lorazepam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when clonazepam is combined with sertraline.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with chlormezanone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with isradipine.


The risk or severity of adverse effects can be increased when thiopental is combined with venlafaxine.


The risk or severity of adverse effects can be increased when thiopental is combined with clemastine.


The risk or severity of adverse effects can be increased when levorphanol is combined with thiamylal.


The risk or severity of adverse effects can be increased when duloxetine is combined with droperidol.


The risk or severity of adverse effects can be increased when levorphanol is combined with desipramine.


The risk or severity of adverse effects can be increased when ethyl icosapentate is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when perphenazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when barnidipine is combined with ropinirole.


The risk or severity of adverse effects can be increased when tiagabine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when barnidipine is combined with metoprolol.


The risk or severity of adverse effects can be increased when levorphanol is combined with halothane.


The risk or severity of adverse effects can be increased when cabergoline is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when zopiclone is combined with maprotiline.


The risk or severity of adverse effects can be increased when Lofexidine is combined with quetiapine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when morphine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when leflunomide is combined with epirizole.


The risk or severity of adverse effects can be increased when morphine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with indomethacin.


The risk or severity of adverse effects can be increased when butamben is combined with carisoprodol.


The risk or severity of adverse effects can be increased when thiothixene is combined with dyclonine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when thiothixene is combined with propoxyphene.


The risk or severity of adverse effects can be increased when methylergonovine is combined with colchicine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when desoximetasone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when suprofen is combined with difluprednate.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with procarbazine.


The risk or severity of adverse effects can be increased when suprofen is combined with halcinonide.


The risk or severity of adverse effects can be increased when butamben is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Agomelatine.


The risk or severity of adverse effects can be increased when benzocaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when ILOPROST is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when enflurane is combined with MELPERONE.


The risk or severity of adverse effects can be increased when moclobemide is combined with terbutaline.


The risk or severity of adverse effects can be increased when LISURIDE is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when rasagiline is combined with bezafibrate.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when imipramine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with thiothixene.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when levorphanol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Etidocaine.


The risk or severity of adverse effects can be increased when enflurane is combined with zotepine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with pimozide.


The risk or severity of adverse effects can be increased when amifostine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with nimesulide.


The risk or severity of adverse effects can be increased when thiopental is combined with thiamylal.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with butalbital.


The risk or severity of adverse effects can be increased when terconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Eprosartan is combined with suprofen.


The risk or severity of adverse effects can be increased when Carbetocin is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when tolazoline is combined with quetiapine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when oxazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when HEROIN is combined with ethotoin.


The risk or severity of adverse effects can be increased when clozapine is combined with quinapril.


The risk or severity of adverse effects can be increased when clozapine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when clozapine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Amrinone.


The risk or severity of adverse effects can be increased when clozapine is combined with bumetanide.


The risk or severity of adverse effects can be increased when timolol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when L-tryptophan is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when hydroxyurea is combined with clozapine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when meprobamate is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when lisinopril is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when lisinopril is combined with felodipine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when lorazepam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when furosemide is combined with streptomycin.


The risk or severity of adverse effects can be increased when meperidine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when clorazepate is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when butalbital is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Icatibant.


The risk or severity of adverse effects can be increased when butalbital is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when furazolidone is combined with formoterol.


The risk or severity of adverse effects can be increased when Talniflumate is combined with diclofenac.


The risk or severity of adverse effects can be increased when meprobamate is combined with tiapride.


The risk or severity of adverse effects can be increased when pimozide is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with proparacaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with amoxapine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Iloperidone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when risperidone is combined with scopolamine.


The risk or severity of adverse effects can be increased when ticlopidine is combined with Apixaban.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with diflorasone.


The risk or severity of adverse effects can be increased when epoprostenol is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when triflupromazine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when epirizole is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when meprobamate is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Retigabine.


The risk or severity of adverse effects can be increased when efavirenz is combined with tizanidine.


The risk or severity of adverse effects can be increased when procarbazine is combined with sulpiride.


The risk or severity of adverse effects can be increased when procarbazine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with acebutolol.


The risk or severity of adverse effects can be increased when furosemide is combined with tobramycin.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with captopril.


The risk or severity of adverse effects can be increased when ketamine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when triamterene is combined with Bretylium.


The risk or severity of adverse effects can be increased when Dothiepin is combined with Bambuterol.


The risk or severity of adverse effects can be increased when docetaxel is combined with Degarelix.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with cabergoline.


The risk or severity of adverse effects can be increased when diflunisal is combined with paramethasone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with dexamethasone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Cladribine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when nimesulide is combined with haloperidol.


The risk or severity of adverse effects can be increased when pargyline is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when Clofarabine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with lisinopril.


The risk or severity of adverse effects can be increased when tetracaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when flumethasone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when secobarbital is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with trandolapril.


The risk or severity of adverse effects can be increased when thalidomide is combined with captopril.


The risk or severity of adverse effects can be increased when reserpine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Perospirone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when docetaxel is combined with teniposide.


The risk or severity of adverse effects can be increased when docetaxel is combined with Epirubicin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when bromazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Tianeptine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when ketoprofen is combined with budesonide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Capsaicin.


The risk or severity of adverse effects can be increased when docetaxel is combined with MEDROGESTONE.


The risk or severity of adverse effects can be increased when Alogliptin is combined with benazepril.


The risk or severity of adverse effects can be increased when docetaxel is combined with Dienogest.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with imipramine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with flumethasone.


The risk or severity of adverse effects can be increased when Risedronic acid is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Apremilast.


The risk or severity of adverse effects can be increased when minoxidil is combined with carvedilol.


The risk or severity of adverse effects can be increased when Regorafenib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when meprobamate is combined with Iloperidone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with procaine.


The risk or severity of adverse effects can be increased when nadolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when butorphanol is combined with phenytoin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with resveratrol.


The risk or severity of adverse effects can be increased when galanthamine is combined with methacholine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Ramelteon.


The risk or severity of adverse effects can be increased when aspirin is combined with salicylamide.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when duloxetine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when triamterene is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Conivaptan is combined with reserpine.


The risk or severity of adverse effects can be increased when isoflurane is combined with tretinoin.


The risk or severity of adverse effects can be increased when azelastine is combined with Apixaban.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when chloroquine is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when buspirone is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when haloprogin is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with benzocaine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Treprostinil is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when ritonavir is combined with triamcinolone.


The risk or severity of adverse effects can be increased when perphenazine is combined with tiapride.


The risk or severity of adverse effects can be increased when niflumic acid is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when promazine is combined with tiagabine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when clomipramine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when fenbufen is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when proparacaine is combined with felbamate.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when quinidine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when dyclonine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when propantheline is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with levorphanol.


The risk or severity of adverse effects can be increased when proparacaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when apomorphine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when olanzapine is combined with primidone.


The risk or severity of adverse effects can be increased when Remoxipride is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Agomelatine.


The risk or severity of adverse effects can be increased when trazodone is combined with imipramine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when trazodone is combined with loratadine.


The risk or severity of adverse effects can be increased when trazodone is combined with meperidine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with suprofen.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with loteprednol.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when lorazepam is combined with venlafaxine.


The risk or severity of adverse effects can be increased when lorazepam is combined with clemastine.


The risk or severity of adverse effects can be increased when thalidomide is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with orphenadrine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when triazolam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with nilvadipine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when clorazepate is combined with midazolam.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with topiramate.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when trazodone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when etizolam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when glutethimide is combined with citalopram.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with mecamylamine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with paroxetine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when triprolidine is combined with ethotoin.


The risk or severity of adverse effects can be increased when flurazepam is combined with proparacaine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with cilostazol.


The risk or severity of adverse effects can be increased when levorphanol is combined with trimipramine.


The risk or severity of adverse effects can be increased when levorphanol is combined with procaine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Halazepam.


The risk or severity of adverse effects can be increased when Butethal is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with promethazine.


The risk or severity of adverse effects can be increased when Butethal is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Halazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when fludiazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when Halazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Lenalidomide is combined with leflunomide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with maprotiline.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with nifedipine.


The risk or severity of adverse effects can be increased when imipramine is combined with bumetanide.


The risk or severity of adverse effects can be increased when Apremilast is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Halazepam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with papaverine.


The risk or severity of adverse effects can be increased when quinidine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when sulfadiazine is combined with prilocaine.


The risk or severity of adverse effects can be increased when ketoconazole is combined with ethanol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with benzocaine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when nimodipine is combined with metolazone.


The risk or severity of adverse effects can be increased when Pentolinium is combined with tubocurarine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Aclidinium is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when thiamylal is combined with Retigabine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when pentamidine is combined with cinnarizine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Ramelteon.


The risk or severity of adverse effects can be increased when felbamate is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when vigabatrin is combined with clomipramine.


The risk or severity of adverse effects can be increased when carprofen is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when spironolactone is combined with penbutolol.


The risk or severity of adverse effects can be increased when fenoprofen is combined with niflumic acid.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with nicardipine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with baclofen.


The risk or severity of adverse effects can be increased when propantheline is combined with propoxyphene.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with oxycodone.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with sertraline.


The risk or severity of adverse effects can be increased when hydromorphone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when prilocaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when loxapine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when brotizolam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when halothane is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when dyclonine is combined with efavirenz.


The risk or severity of adverse effects can be increased when loxapine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when reserpine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Butethal.


The risk or severity of adverse effects can be increased when tolazoline is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when trandolapril is combined with hydralazine.


The risk or severity of adverse effects can be increased when estrone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when dicyclomine is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when diclofenac is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Etomidate is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with HEROIN.


The risk or severity of adverse effects can be increased when estrone is combined with malathion.


The risk or severity of adverse effects can be increased when ibuprofen is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when secobarbital is combined with ethosuximide.


The risk or severity of adverse effects can be increased when captopril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when diflorasone is combined with donepezil.


The risk or severity of adverse effects can be increased when Sacubitril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when amobarbital is combined with Difenoxin.


The risk or severity of adverse effects can be increased when nicardipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when acetaminophen is combined with atorvastatin.


The risk or severity of adverse effects can be increased when moclobemide is combined with bupropion.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when ropinirole is combined with irbesartan.


The risk or severity of adverse effects can be increased when zopiclone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when cabergoline is combined with modafinil.


The risk or severity of adverse effects can be increased when ropinirole is combined with felodipine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with meclizine.


The risk or severity of adverse effects can be increased when Pentolinium is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Limaprost is combined with citric acid.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when sertraline is combined with moclobemide.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Luliconazole.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with diflunisal.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with quazepam.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with prazepam.


The risk or severity of adverse effects can be increased when cinnarizine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Topiroxostat.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with oxprenolol.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when amobarbital is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Halazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when clomipramine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when triamterene is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when pramipexole is combined with mecamylamine.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with propoxyphene.


The risk or severity of adverse effects can be increased when triamterene is combined with lisinopril.


The risk or severity of adverse effects can be increased when nilvadipine is combined with thalidomide.


The risk or severity of adverse effects can be increased when fluoxetine is combined with doxepin.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Lurasidone.


The risk or severity of adverse effects can be increased when sotalol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when desoximetasone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when hydroxyurea is combined with stavudine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when amoxapine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when trimetrexate is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Bretylium.


The risk or severity of adverse effects can be increased when metoprolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when benztropine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Normethadone is combined with Conivaptan.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when halothane is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with phenindione.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when etodolac is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when tiapride is combined with Flibanserin.


The risk or severity of adverse effects can be increased when isoflurane is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when clonazepam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Milnacipran.


The risk or severity of adverse effects can be increased when clonazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when isoflurane is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when levorphanol is combined with butamben.


The risk or severity of adverse effects can be increased when dibucaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when enflurane is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ramipril is combined with sulindac.


The risk or severity of adverse effects can be increased when timolol is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when benztropine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when ketorolac is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when enflurane is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when timolol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Butethal.


The risk or severity of adverse effects can be increased when amiodarone is combined with reserpine.


The risk or severity of adverse effects can be increased when alclofenac is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Phenelzine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when ipratropium is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when ipratropium is combined with Vecuronium.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when ipratropium is combined with pancuronium.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when dibucaine is combined with tiapride.


The risk or severity of adverse effects can be increased when quinapril is combined with Apremilast.


The risk or severity of adverse effects can be increased when metaproterenol is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with ethotoin.


The risk or severity of adverse effects can be increased when benzocaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when pimozide is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when donepezil is combined with Varenicline.


The risk or severity of adverse effects can be increased when pimozide is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Flupentixol.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with efavirenz.


The risk or severity of adverse effects can be increased when Isoconazole is combined with nimodipine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with desipramine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when amobarbital is combined with chlormezanone.


The risk or severity of adverse effects can be increased when trimeprazine is combined with clomipramine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Iloperidone.


The risk or severity of adverse effects can be increased when timolol is combined with enalapril.


The risk or severity of adverse effects can be increased when amobarbital is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when amobarbital is combined with Escitalopram.


The risk or severity of adverse effects can be increased when trimipramine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when oxprenolol is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when nabumetone is combined with diflunisal.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with Vilazodone.


The risk or severity of adverse effects can be increased when atenolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when bromazepam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when cilazapril is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when thiopental is combined with prilocaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when procarbazine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when bromazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with zotepine.


The risk or severity of adverse effects can be increased when clorazepate is combined with meclizine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with thioridazine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when secobarbital is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when secobarbital is combined with baclofen.


The risk or severity of adverse effects can be increased when procaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when moclobemide is combined with Asenapine.


The risk or severity of adverse effects can be increased when haloperidol is combined with diazepam.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Articaine.


The risk or severity of adverse effects can be increased when ketorolac is combined with loteprednol.


The risk or severity of adverse effects can be increased when Tolcapone is combined with cetirizine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when benzphetamine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Metixene is combined with Normethadone.


The risk or severity of adverse effects can be increased when Trospium is combined with propoxyphene.


The risk or severity of adverse effects can be increased when nicergoline is combined with clindamycin.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when pramipexole is combined with methazolamide.


The risk or severity of adverse effects can be increased when indapamide is combined with deslanoside.


The risk or severity of adverse effects can be increased when methylene blue is combined with brimonidine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with triprolidine.


The risk or severity of adverse effects can be increased when clozapine is combined with loxapine.


The risk or severity of adverse effects can be increased when losartan is combined with floctafenine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when enflurane is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when benzocaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when enflurane is combined with duloxetine.


The risk or severity of adverse effects can be increased when Spirapril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when benzocaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when enflurane is combined with topiramate.


The risk or severity of adverse effects can be increased when procaine is combined with etizolam.


The risk or severity of adverse effects can be increased when carbamazepine is combined with glutethimide.


The risk or severity of adverse effects can be increased when morphine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Halazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when Halazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with dibucaine.


The risk or severity of adverse effects can be increased when cerulenin is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when alprazolam is combined with felbamate.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with donepezil.


The risk or severity of adverse effects can be increased when duloxetine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when benazepril is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when benazepril is combined with quinapril.


The risk or severity of adverse effects can be increased when pentazocine is combined with thioridazine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when efavirenz is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Halazepam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with proparacaine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with felbamate.


The risk or severity of adverse effects can be increased when butabarbital is combined with chlormezanone.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when halothane is combined with Sacubitril.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when butabarbital is combined with phenobarbital.


The risk or severity of adverse effects can be increased when butabarbital is combined with Escitalopram.


The risk or severity of adverse effects can be increased when thiopental is combined with etizolam.